The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA | Zendy

Hannah Griffith | Zendy; Andrew Wiese | Zendy; Edward F. Mitchel | Zendy; Carlos G. Grijalva | Zendy

Open Access

The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media–Related Antibiotic Use Among Young Children in Tennessee, USA

Author(s) -

Hannah Griffith,

Andrew Wiese,

Edward F. Mitchel,

Carlos G. Grijalva

Publication year - 2022

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofac019

Subject(s) - medicine , pneumococcal conjugate vaccine , otitis , acute otitis media , antibiotics , streptococcus pneumoniae , pediatrics , conjugate vaccine , microbiology and biotechnology , surgery , biology

Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research